Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Podcasts
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 73, Issue 12
Tofacitinib, a JAK inhibitor, inhibits human B cell activation in vitro
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Letters
Tofacitinib, a JAK inhibitor, inhibits human B cell activation in vitro
Online download statistics by month:
Online download statistics by month: August 2014 to March 2024
Abstract
Full
Pdf
Aug 2014
409
44
65
Sep 2014
149
55
47
Oct 2014
139
33
33
Nov 2014
179
43
69
Dec 2014
37
16
30
Jan 2015
49
26
36
Feb 2015
28
18
10
Mar 2015
49
31
28
Apr 2015
30
13
12
May 2015
31
8
13
Jun 2015
20
14
18
Jul 2015
33
13
17
Aug 2015
39
7
13
Sep 2015
41
8
11
Oct 2015
38
5
6
Nov 2015
39
5
10
Dec 2015
44
12
15
Jan 2016
43
13
15
Feb 2016
34
11
15
Mar 2016
21
17
11
Apr 2016
37
8
6
May 2016
60
8
13
Jun 2016
29
14
17
Jul 2016
34
17
25
Aug 2016
39
14
24
Sep 2016
54
13
24
Oct 2016
45
13
28
Nov 2016
40
3
13
Dec 2016
35
5
26
Jan 2017
34
12
17
Feb 2017
36
15
15
Mar 2017
36
14
17
Apr 2017
50
23
21
May 2017
58
15
54
Jun 2017
63
10
53
Jul 2017
77
9
25
Aug 2017
79
6
25
Sep 2017
124
10
22
Oct 2017
117
20
22
Nov 2017
96
5
17
Dec 2017
62
2
9
Jan 2018
84
7
17
Feb 2018
93
10
15
Mar 2018
45
7
5
Apr 2018
34
5
2
May 2018
51
10
6
Jun 2018
61
5
3
Jul 2018
76
10
11
Aug 2018
43
4
3
Sep 2018
58
5
5
Oct 2018
41
10
8
Nov 2018
57
10
8
Dec 2018
62
7
9
Jan 2019
66
12
7
Feb 2019
50
11
5
Mar 2019
55
8
4
Apr 2019
133
6
7
May 2019
44
4
3
Jun 2019
40
10
9
Jul 2019
34
4
5
Aug 2019
23
6
1
Sep 2019
33
2
3
Oct 2019
84
9
8
Nov 2019
47
6
5
Dec 2019
48
5
4
Jan 2020
82
6
5
Feb 2020
73
11
10
Mar 2020
41
1
3
Apr 2020
52
6
4
May 2020
39
0
1
Jun 2020
37
1
3
Jul 2020
53
3
1
Aug 2020
60
6
9
Sep 2020
76
7
5
Oct 2020
47
6
7
Nov 2020
72
8
4
Dec 2020
61
1
3
Jan 2021
71
8
8
Feb 2021
49
5
2
Mar 2021
36
5
3
Apr 2021
54
4
2
May 2021
19
1
0
Jun 2021
8
8
3
Jul 2021
3
3
2
Aug 2021
10
9
2
Sep 2021
8
5
1
Oct 2021
68
13
5
Nov 2021
58
3
1
Dec 2021
33
7
2
Jan 2022
135
8
6
Feb 2022
75
3
2
Mar 2022
53
3
4
Apr 2022
53
3
1
May 2022
63
6
4
Jun 2022
104
2
2
Jul 2022
34
2
1
Aug 2022
63
8
4
Sep 2022
47
7
0
Oct 2022
65
2
1
Nov 2022
36
2
0
Dec 2022
59
4
3
Jan 2023
50
2
3
Feb 2023
84
2
1
Mar 2023
75
10
8
Apr 2023
28
2
3
May 2023
50
7
3
Jun 2023
31
7
6
Jul 2023
19
5
0
Aug 2023
50
5
3
Sep 2023
39
4
1
Oct 2023
44
7
4
Nov 2023
59
10
2
Dec 2023
73
12
1
Jan 2024
82
7
2
Feb 2024
45
10
1
Mar 2024
45
6
3
Total
6690
1074
1255
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?